Surgery
Volume 148, Issue 4 , Pages 867-875 , October 2010

Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy

  • Adrienne L. Melck, MD, MPH

      Affiliations

    • Section of Endocrine Surgery, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA
    • ,
  • Sally E. Carty, MD

      Affiliations

    • Section of Endocrine Surgery, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA
    • Corresponding Author InformationReprint requests: Sally E. Carty, MD, Suite 101, 3471 Fifth Avenue, Pittsburgh, PA 15213.
    • ,
  • Raja R. Seethala, MD

      Affiliations

    • Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA
    • ,
  • Michaele J. Armstrong, PhD

      Affiliations

    • Section of Endocrine Surgery, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA
    • ,
  • Michael T. Stang, MD

      Affiliations

    • Section of Endocrine Surgery, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA
    • ,
  • Jennifer B. Ogilvie, MD

      Affiliations

    • Section of Endocrine Surgery, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA
    • ,
  • Linwah Yip, MD

      Affiliations

    • Section of Endocrine Surgery, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA

,Accepted 15 July 2010.

References 

  1. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658–5671
  2. Decker PA, Cohen EP, Doffek KM, Ashley BA, Bienemann ME, Zhu YR, et al. Subtotal parathyroidectomy in renal failure: still needed after all these years. World J Surg. 2001;25:708–712
  3. Jaskowiak N, Norton JA, Alexander HR, Doppman JL, Shawker T, Skarulis M, et al. A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg. 1996;224:308–320discussion 320-1
  4. Grant CS, van Heerden JA, Charboneau JW, James EM, Reading CC. Clinical management of persistent and/or recurrent primary hyperparathyroidism. World J Surg. 1986;10:555–565
  5. Wells SA, Gunnells JC, Shelburne JD, Schneider AB, Sherwood LM. Transplantation of the parathyroid glands in man: clinical indications and results. Surgery. 1975;78:34–44
  6. Carty SE, Norton JA. Management of patients with persistent or recurrent primary hyperparathyroidism. World J Surg. 1991;15:716–723
  7. Kievit AJ, Tinnemans JG, Idu MM, Groothoff JW, Surachno S, Aronson DC. Outcome of total parathyroidectomy and autotransplantation as treatment of secondary and tertiary hyperparathyroidism in children and adults. World J Surg. 2010;34:993–1000
  8. Wells SA, Farndon JR, Dale JK, Leight GS, Dilley WG. Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg. 1980;192:451–458
  9. Gagne ER, Urena P, Leite-Silva S, Zingraff J, Chevalier A, Sarfati E, et al. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol. 1992;3:1008–1017
  10. Feldman AL, Sharaf RN, Skarulis MC, Bartlett DL, Libutti SK, Weinstein LS, et al. Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery. 1999;126:1042–1048
  11. Carty SE, Worsey J, Virji MA, Brown ML, Watson CG. Concise parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay. Surgery. 1997;122:1107–1114discussion 1114-6
  12. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1–201
  13. Zimering MB, Brandi ML, deGrange DA, Marx SJ, Streeten E, Katsumata N, et al. Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1990;70:149–154
  14. Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, Uchida K, et al. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg. 1996;20:744–750discussion 750-2
  15. Norton JA, Venzon DJ, Berna MJ, Alexander HR, Fraker DL, Libutti SK, et al. Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and zollinger-ellison syndrome: Long-term outcome of a more virulent form of HPT. Ann Surg. 2008;247:501–510
  16. Rothmund M, Wagner PK, Schark C. Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: A randomized trial. World J Surg. 1991;15:745–750
  17. Elaraj DM, Skarulis MC, Libutti SK, Norton JA, Bartlett DL, Pingpank JF, et al. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003;134:858–864discussion 864-5
  18. Tublin ME, Yim JH, Carty SE. Recurrent hyperparathyroidism secondary to parathyromatosis: clinical and imaging findings. J Ultrasound Med. 2007;26:847–851

PII: S0039-6060(10)00405-8

doi: 10.1016/j.surg.2010.07.037

Surgery
Volume 148, Issue 4 , Pages 867-875 , October 2010

Article Tools

* Image Usage & Resolution